Meta and Google expanded collaboration funding to create virtual cell models, aiming to predict cellular behavior with AI-driven biology and simulation workflows. The project is positioned to move from concept toward building AI-ready models that can support experimentation and reduce iteration cycles. While details and timelines remain open, the pairing of major compute and platform capabilities with structured biology modeling could accelerate in silico hypothesis testing—especially if evaluation frameworks catch up to model calibration and uncertainty measurement. For the biotech sector, the key near-term watch item is whether virtual cell systems become practically usable for regulated research workflows, including reproducible benchmarking and transparent model performance across perturbations.